Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Brachytherapy. Found 43 abstracts

no pagination
Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Gynecol Oncol. 2019 Mar;152(3):540-7.
Holschneider CH, Petereit DG, Chu C, Hsu IC, Ioffe YJ, Klopp AH, Pothuri B, Chen LM, Yashar C. Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS). Brachytherapy. 2019 Mar;18(2):123-32.
Sandler KA, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Song DY, Klein EA, Stephenson AJ, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco SC, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR, Kishan AU. Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. Eur Urol. 2019 Apr 13;.
Kishan AU, Cook RR, Ciezki JP, Ross AE, Pomerantz MM, Nguyen PL, Shaikh T, Tran PT, Sandler KA, Stock RG, Merrick GS, Demanes DJ, Spratt DE, Abu-Isa EI, Wedde TB, Lilleby W, Krauss DJ, Shaw GK, Alam R, Reddy CA, Stephenson AJ, Klein EA, Song DY, Tosoian JJ, Hegde JV, Yoo SM, Fiano R, D'Amico AV, Nickols NG, Aronson WJ, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese TL, Reiter RE, Said JW, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. Jama. 2018 Mar 06;319(9):896-905.   PMCID: PMC5885899
Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Skin CanceR Brachytherapy vs External beam radiation therapy (SCRiBE) meta-analysis. Radiother Oncol. 2018 Mar;126(3):386-93.
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Jordan SE, Micaily I, Hernandez E, Ferriss JS, Miyamoto CT, Li S, Micaily B. Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma. Brachytherapy. 2017 Nov;16(6):1144-51.
Kishan AU, Shaikh T, Wang PC, Reiter RE, Said J, Raghavan G, Nickols NG, Aronson WJ, Sadeghi A, Kamrava M, Demanes DJ, Steinberg ML, Horwitz EM, Kupelian PA, King CR. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol. 2017 May;71(5):766-73.
Xu MJ, Chu C, Rubin S, Lin LL. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma. Am J Clin Oncol. 2017 Dec;40(6):598-604.   PMCID: PMC4733581
Guttmann DM, Li H, Sevak P, Grover S, Jacobson G, Feldman A, Rubin S, Chu C, Bhatia S, Elshaikh MA, Lin LL. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2016 Jan;26(1):141-8.
Kennedy AS, Ball DS, Cohen SJ, Cohn M, Coldwell D, Drooz A, Ehrenwald E, Kanani S, Rose SC, Nutting CW, Moeslein FM, Savin MA, Schirm S, Putnam SG, Sharma NK, Wang EA, Metastatic Colorectal Cancer Liver Metastases Outcomes After Radioembolization Study I. Safety and Efficacy of Radioembolization in Elderly (>/= 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer. Clin Colorectal Cancer. 2016 Jun;15(2):141-151 e6.
Shaikh T, Wang L, Ruth K, Hallman M, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM. The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016 Jan 29;15(2):156-62.   PMCID: PMC4789160
Zaorsky NG, Shaikh T, Murphy CT, Hallman MA, Hayes SB, Sobczak ML, Horwitz EM. Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer. Cancer Treat Rev. 2016 Jun 17;48:50-60.
Murphy CT, Heller S, Ruth K, Buyyounouski MK, Weinberg D, Uzzo RG, Plimack E, Kutikov A, Chen DY, Horwitz EM. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. Practical radiation oncology. 2015 May;5(3):e215-e222.   PMCID: Needs PMCID
Shaikh T, Zaorsky NG, Ruth K, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM. Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment. Brachytherapy. 2015 Jan;14(3):316-21.   PMCID: 4424094
Chibani O, Ma CM. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators. Med Phys. 2014 May;41(5):051712.
Kim SP, Gross CP, Nguyen PL, Smaldone MC, Shah ND, Karnes RJ, Thompson RH, Han LC, Yu JB, Trinh QD, Ziegenfuss JY, Sun M, Tilburt JC. Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists. Med Care. 2014 Jul;52(7):579-85.
Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014 Jul 15;120(14):2114-21.   PMCID: 4429530
Pisansky TM, Pugh SL, Greenberg RE, Pervez N, Reed DR, Rosenthal SA, Mowat RB, Raben A, Buyyounouski MK, Kachnic LA, Bruner DW. Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: the Radiation Therapy Oncology Group [0831] randomized clinical trial. Jama. 2014 Apr 02;311(13):1300-7.   PMCID: 4669050
Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma. Brachytherapy. 2014 Sep;13(5):456-64.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Brachytherapy

Brachytherapy Middle Aged Aged radiotherapy 80 and over Aged Adult Prostatic Neoplasms Male Retrospective Studies methods therapeutic use Female Prostate cancer Radiotherapy Dosage therapy pathology Prostatectomy Local Neoplasm Recurrence mortality Computer-Assisted Radiotherapy Planning Treatment Outcome Radiotherapy Neoplasm Staging Neoplasm Grading Endometrial Neoplasms Endometrioid Carcinoma Comparative effectiveness research Survival Rate Lymph Node Excision Adjuvant Radiotherapy Endometrial cancer Combined Modality Therapy Neoplasm Metastasis adverse effects Imrt Carcinosarcoma Cohort Studies Ultrasonography Kaplan-Meier Estimate diagnostic imaging X-Ray Computed Tomography Computer assisted dosimetry calculations Multivariate Analysis Magnetic Resonance Imaging Proportional Hazards Models Follow-Up Studies etiology Three-Dimensional Imaging Cervical cancer Adenocarcinoma Radiation therapy Hysterectomy statistics & numerical data Sbrt Prognosis United States Androgen Antagonists Antineoplastic Combined Chemotherapy Protocols Endometrioid adenocarcinoma Intracavitary brachytherapy Primary chemoradiation Marriage clinical practice patterns LDR Quality assurance radiation effects Erectile Dysfunction Proton therapy Health Insurance Radical prostatectomy Cost-Benefit Analysis Esophageal Neoplasms Suburban Population Skin cancer Medical student Pelvic Neoplasms Meta-analysis Gleason 10 Sexual Behavior Clear Cell Adenocarcinoma Propensity Score Radiation Injuries Uterine Cervical Neoplasms Educational Status anatomy & histology Factual Databases epidemiology administration & dosage Chemoradiotherapy Survival Analysis Systematic review Metastases blood Disease Progression surgery Urban Population drug therapy Rural Population Monte Carlo Method Personalized medicine trends contraindications use Salvage Therapy Abdominal Neoplasms Photons Tumor Biomarkers utilization Gastrointestinal Diseases Water Basal cell carcinoma Technology Registries Gleason 9 Ldr Training Biological Models Risk Factors Squamous cell carcinoma Iridium Radioisotopes Paclitaxel Prostate-Specific Antigen Spinal Cord Intensity-Modulated Radiotherapy Watchful Waiting Low-dose rate Radiation Oncology Medicare secondary Utilization Review Carboplatin Psychological Adaptation D90 Urology Biochemical control Physician's Practice Patterns Algorithms Adjuvant Chemotherapy Neoplasm Invasiveness economics Double-Blind Method Ulcerative Colitis Patient Selection V100 Inflammatory Bowel Diseases Treatment Failure Conformal Radiotherapy Quality of life Cystic Neoplasms-Mucinous-and Serous ethnology
Last updated on Monday, November 04, 2019